Effective
closure of surgical incisions plays a crucial role in post-surgical
process to regain normal anatomical functions and maintain the
integrity of tissues. Thus, the primary objective of surgical
incision closure devices is to stop bleeding i.e. hemostasis and to
close or seal the wound both externally and internally. Failure to
close surgical incisions effectively can lead to severe medical
complications such as infection and scarring. The commonly involved
technique in conventional surgical incision closure is the use of
surgical sutures for stitching together the incised skin edges. But
modern methods introduced are more advanced and convenient; to
mention some of the advanced methods - use of adhesives, hemostats,
medical staples and sealants.
The
commonly used surgical incision closure products include:
- Surgical sutures
- Absorbable
- Non-absorbable
- Hemostats
- Collagen based
- Oxidized regenerated cellulose based
- Thrombin based
- Ligating clips
- Medical staples
- Tissue sealants
- External
- Internal
Technologically
advanced surgical incision closure devices, for instance, tissue
sealants, hemostats and similar other devices play an important role
in driving the market due to benefits offered such as fewer traumas,
reduced risk of infections, better cosmetic outcomes and reduced
recovery time. Also, there are many surgical incision closure
products in the pipeline that are exploring usage of alternative
materials, for example, titanium suture needles to replace medical
grade stainless steel needles used for suturing among others; thus
high investment in R&D is likely to lead the development and
supply of newer, effective surgical incision closure products. This
in turn is likely to drive the demand for surgical incision closure
products in the future. However, the growth of such devices could be
hindered in the future due to rise in preference for minimally
invasive surgical procedures among patients.
North
America followed by Europe are expected to be the largest markets
owing to a high consumer base of aesthetic surgeries, knee
replacement surgeries, hip replacement surgeries and spinal fusions.
Asia-Pacific is estimated to register a remarkable growth because of
few notable reasons such as improvements in healthcare
infrastructure, increased access to healthcare services,
establishment of new hospitals and diagnostic centers and rising
spends in the healthcare segment.
Few
of the leading companies involved in the development, manufacturing
and distribution of surgical incision closure devices are 3M
HealthCare, Axya Medical, Inc., Baxter International Inc., BTG
International, Inc., Covidien Ltd., CryoLife, Inc., Ethicon Inc.,
Genzyme Biosurgery, Inc, Henkel Loctite Corporation/Henkel Group,
Smith & Nephew PLC, Tyco Healthcare/Tyco International among
others.
Enquiry
Before Buying :-
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2138
Browse
Market Research Blogs:
No comments:
Post a Comment